This clinical trial is focused on patients undergoing cardiac surgery, specifically those who have a procedure called a sternotomy, which involves opening the chest to access the heart. The study is investigating the effects of a treatment called a para-sternal block, which is a type of local anesthesia that numbs the area around the sternum to help manage pain after surgery. The medication used for this block is called Ropivacaine, which is a local anesthetic that helps reduce pain by blocking nerve signals in the body.
The purpose of the study is to compare how this type of anesthesia affects breathing function after surgery. Participants will be randomly assigned to receive either the para-sternal block with Ropivacaine or a placebo. The study will monitor participants’ breathing and pain levels at various times after surgery, including the first day, the second day, and two months later. Breathing function will be measured using a test called spirometry, which checks how well the lungs are working by measuring the amount of air a person can exhale.
Throughout the study, researchers will also assess pain levels using a simple scale from 0 to 10, where 0 means no pain and 10 means the worst pain imaginable. Other aspects of recovery, such as the need for additional pain medication and any complications related to breathing, will also be monitored. The study aims to provide valuable information on whether the para-sternal block with Ropivacaine can improve recovery and comfort for patients after cardiac surgery.



France